Who are Sevoflurane+Nitrous oxide's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Methoxyflurane, MEOF, Sevoflurane Inhalational Induction and Maintenance, Desflurane Inhalant Product, Methoxyflurane - Penthrox.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sevoflurane-nitrous-oxide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Sevoflurane+Nitrous oxide — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sevoflurane+Nitrous oxide (Sevoflurane+Nitrous oxide) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: General anesthetic (volatile anesthetic + inhalational anesthetic). Area: Anesthesiology.

marketed General anesthetic (volatile anesthetic + inhalational anesthetic) GABA receptors, NMDA receptors Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Sevoflurane+Nitrous oxide (Sevoflurane+Nitrous oxide) — Huazhong University of Science and Technology. Sevoflurane and nitrous oxide are volatile anesthetic agents that depress the central nervous system to produce unconsciousness and analgesia for surgical procedures.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Sevoflurane+Nitrous oxide TARGET	Sevoflurane+Nitrous oxide	Huazhong University of Science and Technology	marketed	General anesthetic (volatile anesthetic + inhalational anesthetic)	GABA receptors, NMDA receptors
Methoxyflurane, MEOF	Methoxyflurane, MEOF	Sunnybrook Health Sciences Centre	marketed	Volatile halogenated ether anesthetic	GABA receptors, NMDA receptors
Sevoflurane Inhalational Induction and Maintenance	Sevoflurane Inhalational Induction and Maintenance	Abbott	marketed	Volatile anesthetic agent	GABA receptors, NMDA receptors, potassium channels
Desflurane Inhalant Product	Desflurane Inhalant Product	Sichuan Provincial People's Hospital	marketed	Volatile inhalational anesthetic	GABA receptors, NMDA receptors, potassium channels
Methoxyflurane - Penthrox	Methoxyflurane - Penthrox	St. Paul's Hospital, Canada	phase 3	Volatile halogenated anesthetic	GABA receptors, NMDA receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (General anesthetic (volatile anesthetic + inhalational anesthetic) class)

Huazhong University of Science and Technology · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sevoflurane+Nitrous oxide — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-nitrous-oxide. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing